Sarcoidosis-associated pulmonary hypertension: Assessment and management

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 4, 2010, Pages 494-500

  Palmero, Veronica ^a,b   Sulica, Roxana ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

pulmonary hypertension; Sarcoidosis; treatment

Indexed keywords

BOSENTAN; CORTICOSTEROID; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PHOSPHODIESTERASE V INHIBITOR; PREDNISOLONE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; UNIPROST; PHOSPHODIESTERASE INHIBITOR;

COUGHING; DISEASE ASSOCIATION; FUNCTIONAL STATUS; HEMODYNAMICS; HUMAN; HYPOXEMIA; LUNG BLOOD VESSEL; LUNG FIBROSIS; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; COMPLICATION; HYPERTENSION, PULMONARY; PULMONARY FIBROSIS;

ENDOTHELIN RECEPTOR ANTAGONISTS; HUMANS; HYPERTENSION, PULMONARY; PHOSPHODIESTERASE 5 INHIBITORS; PHOSPHODIESTERASE INHIBITORS; PROGNOSIS; PROSTAGLANDINS I; PULMONARY FIBROSIS; SARCOIDOSIS;

EID: 77955025019     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1262217     Document Type: Review

References (32)

1. Shigemitsu H, Nagai S, Sharma O P. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007 13 434-438
2. Badesch D B., Champion H C., Sanchez M A. et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009 54 (1, Suppl) S55-S66
3. Simonneau G, Robbins I M., Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009 54 (1, Suppl) S43-S54
4. Baughman R P., Engel P J., Meyer C A., Barrett A B., Lower E E. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 23 108-116
5. Handa T, Nagai S, Miki S et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006 129 1246-1252
6. Shorr A F., Helman D L., Davies D B., Nathan S D. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005 25 783-788
7. Sulica R, Teirstein A S., Kakarla S, Nemani N, Behnegar A, Padilla M L. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005 128 1483-1489
8. Nunes H, Humbert M, Capron F et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006 61 68-74
9. Takemura T, Matsui Y, Oritsu M et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies. Virchows Arch A Pathol Anat Histopathol 1991 418 361
10. Rosen Y, Moon S, Huang C T., Gourin A, Lyons H A. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med 1977 101 170-174
11. Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol 1992 23 1216-1223
12. Westcott J L., DeGraff A C. Jr. Sarcoidosis, hilar adenopathy, and pulmonary artery narrowing. Radiology 1973 108 585-586
13. Damuth T E., Bower J S., Cho K, Dantzker D R. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980 78 888-891
14. Sperling R T., Creager M A. Nitric oxide and pulmonary hypertension. Coron Artery Dis 1999 10 287-294
15. Preston I R., Klinger J R., Landzberg M J., Houtchens J, Nelson D, Hill N S. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest 2001 120 866-872
16. Giaid A, Yanagisawa M, Langleben D et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993 328 1732-1739 (Pubitemid 23170122)
17. Sofia M, Mormile M, Faraone S, Alifano M, Carrat P, Carrat L. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases. Sarcoidosis 1995 12 118-123
18. Letizia C, Danese A, Reale M G. et al. Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission. Panminerva Med 2001 43 257-261
19. Reichenberger F, Schauer J, Kellner K, Sack U, Stiehl P, Winkler J. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung 2001 179 163-174
20. Baughman R P., Sparkman B K., Lower E E. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007 132 207-213
21. Arcasoy S M., Christie J D., Ferrari V A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003 167 735-740
22. Gluskowski J, Hawrylkiewicz I, Zych D, Zieliski J. Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Eur Respir J 1990 3 403-407
23. Fisher K A., Serlin D M., Wilson K C., Walter R E., Berman J S., Farber H W. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment. Chest 2006 130 1481-1488
24. Baughman R P., Judson M A., Lower E E. et al. Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis 2009 26 110
25. Milman N, Burton C M., Iversen M, Videbaek R, Jensen C V., Carlsen J. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant 2008 27 329-334
26. Foley R J., Metersky M L. Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration 2008 75 211-214
27. Barnett C F., Bonura E J., Nathan S D. et al. Treatment of sarcoidosis-associated pulmonary hypertension: a two-center experience. Chest 2009 135 1455-1461
28. Macfarlane J T. Prognosis in sarcoidosis. Br Med J (Clin Res Ed) 1984 288 1557-1558
29. Lynch J P. III, Kazerooni E A., Gay S E. Pulmonary sarcoidosis. Clin Chest Med 1997 18 755-785
30. Arcasoy S M., Christie J D., Pochettino A et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001 120 873-880
31. Shorr A F., Davies D B., Nathan S D. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002 122 233-238
32. Shorr A F., Davies D B., Nathan S D. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003 124 922-928